Huda Y Zoghbi sold $7.2M of REGN stock

Huda Y Zoghbi, Dir of Regeneron Pharmaceuticals, Inc. (REGN), sold 7,439 shares of REGN stock worth $7.2M, per an SEC Form 4 filed Nov 5, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 3, 2026, 2 days before it was made public.

REGN has moved -7.1% since the trade date, from $973.36 to $904.35 (Nov 6, 2026 close).